Pamela Esposito - 15 Jul 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Chief Business Officer
Signature
/s/ Jean Franchi, attorney-in-fact
Issuer symbol
REPL
Transactions as of
15 Jul 2021
Net transactions value
-$148,856
Form type
4
Filing time
19 Jul 2021, 21:02:56 UTC
Previous filing
17 Jun 2021
Next filing
22 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REPL Common Stock Options Exercise $4,646 +4,600 +2.2% $1.01* 214,759 15 Jul 2021 Direct
transaction REPL Common Stock Sale $153,502 -4,600 -2.1% $33.37 210,159 15 Jul 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REPL Employee Stock Option (right to buy) Options Exercise $0 -4,600 -6.3% $0.000000 68,603 15 Jul 2021 Common Stock 4,600 $1.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2 Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 544,267 shares of the Issuer's common stock, 345,191 of which are exercisable as of the date hereof.
F3 The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.